John Bell, Université de Sherbrooke

Research

Cancer Immunotherapy Chimeric Antigen Receptor T Cell Therapy Experimental Rigour Multilaboratory Study Natural Killer Cell Therapy Oncolytic Virus Therapy Translation Tumour Infiltrating Lymphocyte Therapy

Latest funding

Preclinical multilaboratory studies for cancer immunotherapy
CIHR · 2023 · Principal investigator
$10,000

All 1 grants and awards

Preclinical multilaboratory studies for cancer immunotherapy

Principal investigatorCIHR2023Planning and Dissemination Grant - Institute Community Support

Principal investigators: Tai, Lee-Hwa; Bell, John C; Lalu, Manoj M

Keywords: Cancer Immunotherapy; Chimeric Antigen Receptor T Cell Therapy; Experimental Rigour; Multilaboratory Study; Natural Killer Cell Therapy; Oncolytic Virus Therapy; Translation; Tumour Infiltrating Lymphocyte Therapy

$10,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Cancer Immunotherapy Dear Professor Bell, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on cancer immunotherapy connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Preclinical multilaboratory studies for cancer immunotherapy" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]